Preparation and Evaluation of Sustained Release Matrix Tablets of Tramadol Hydrochloride Using Glyceryl Palmitostearate

被引:0
作者
Deore, Rakesh K. [1 ]
Kavitha, Kunchu [1 ]
Tamizhmani, Theetha G. [1 ]
机构
[1] Bharathi Coll Pharm, Dept Pharmaceut, Bharathinagar 571422, Karnataka, India
关键词
Tramadol hydrochloride; Glyceryl palmitostearate; Melt granulation; Direct compression; Sustained release; COMPRITOL(R);
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To prepare oral sustained release matrix tablets of a highly water soluble drug, tramadol hydrochloride, and to evaluate the effect of concentration of the hydrophobic polymer content and method of preparation on drug release. Methods: The tablets were a mixture of both tramadol hydrochloride and glyceryl palmitostearate (GP) prepared by melt granulation (MG1, MG2, MG3 and MG4 in ratios 1: 1, 1: 2, 1: 3 and 1: 4, respectively) or by direct compression (DC, 1: 2 ratio). The hardness of the tablets was measured. Drug/GP interaction was determined by FT-IR spectroscopy while drug release from the matrix tablets was studied using USP II dissolution apparatus. The release data were subjected to different models in order to evaluate their release kinetics and mechanisms. Results: The hardness of the tablets was in the range of 5.30 +/- 0.36 - 6.50 +/- 0.10 kg/cm(2). FT-IR spectra showed that there was no clear interaction between the drug and the glyceride. Of the formulations (MG1 to MG4) prepared by melt granulation, MG4 showed the most suitable sustained release, 58.4 +/- 1.1 % in 12 h (p < 0.05). Drug release (98.2 +/- 0.2 % in 8 h) was highest for DC which was prepared by direct compression. Also, drug release mechanism for the formulations was by Fickian diffusion. Conclusion: Glyceryl palmitostearate is a suitable matrix-forming agent to sustain the release of a water-soluble drug such as tramadol hydrochloride. Melt granulation was a better technique for formulating the product than direct compression.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 22 条
[1]   Compritol® 888 ATO:: an innovative hot-melt coating agent for prolonged-release drug formulations [J].
Barthelemy, P ;
Laforêt, JP ;
Farah, N ;
Joachim, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (01) :87-90
[2]  
BODMEIER RA, 1998, ENCY PHARM TECHNOLOG, V3, P2988
[3]  
CHAUDHARI PD, 2006, MELT GRANULATION TEC
[4]  
GUDSOORKAR VR, 1997, E PHARM, V40, P111
[5]   Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets [J].
Hamdani, J ;
Moës, AJ ;
Amighi, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 260 (01) :47-57
[6]   Development and evaluation of prolonged release pellets obtained by the melt pelletization process [J].
Hamdani, J ;
Moës, AJ ;
Amighi, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) :167-177
[7]  
Harland R, 2003, J CONTROL REL, V6, P282
[9]   MECHANISMS OF SOLUTE RELEASE FROM POROUS HYDROPHILIC POLYMERS [J].
KORSMEYER, RW ;
GURNY, R ;
DOELKER, E ;
BURI, P ;
PEPPAS, NA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (01) :25-35
[10]  
Lehmann KA, 1997, DRUGS, V53, P25, DOI 10.2165/00003495-199700532-00007